Essential Resources for Nephrology - Medscape
2008年5月9日 · Here, you can auto-calculate the A-a gradient, anion gap, Cockcroft-Gault glomerular filtration rate, free water deficit, Modification of Diet in Renal Disease glomerular …
Diabetes Insipidus as a Complication after Pituitary Surgery
Desmopressin is the drug of choice for acute and chronic treatment of central diabetes insipidus. [] Treatment results in a prompt reduction of urine output and antidiuresis, which generally lasts ...
Adult ADHD Diagnosis Linked to Earlier Death - Medscape
2025年1月23日 · Diagnosis of ADHD was tied to a 7-9-year reduction in life expectancy in adults compared to peers without ADHD, new data reveals.
Critical Care Pearl: Metabolic Acidosis - Medscape
2013年8月19日 · HCO3 deficit (mEq) = 0.6 x wt (kg) x (15* - measured HCO3) *Here, 15 is chosen as the end-point goal To choose a rate, the bicarbonate deficit should be divided with …
How Do Ferritin Cutoffs Affect Diagnosis Rates? - Medscape
2024年8月12日 · TOPLINE: Ferritin cutoffs of 30 and 45 ng/mL are linked to higher iron deficiency diagnosis rates than a cutoff of 15 ng/mL in patients with nonanemia and anemia.. …
Sedative, Hypnotic Drug Misuse in Young Adults Up 5x - Medscape
2025年1月29日 · More teens and young adults appear to be developing addiction or dependence on drugs that help them sleep, calm down, and manage anxiety. The prevalence of sedative, …
Alpha-Gal Syndrome: 5 Things to Know - Medscape
2024年12月18日 · Alpha-gal syndrome (AGS), a tickborne disease commonly called “red meat allergy,” is a serious, potentially life-threatening allergy to the carbohydrate alpha-gal.
T-DXd Effective in HR+/HER2-Low BC After Endocrine Failure
2024年12月19日 · Cite this: T-DXd Shows Consistent Benefit Across Endocrine-Resistant HR+/HER2-Low Breast Cancer Subgroups - Medscape - December 19, 2024.
Obesity Week 2024 - Medscape
2024年11月6日 · Obesity Week 2024 : Read clinically focused news coverage of key developments from Obesity Week 2024
Has Tirzepatide Scaled the HFpEF/Obesity SUMMIT? - Medscape
2024年12月3日 · The GIP/GLP-1 receptor agonist reduced events in patients with HFpEF and obesity. John Mandrola questions whether it changed the disease trajectory, as the …